Cosmetic Surgery Market

Growing demand for cosmetic surgeries and minimally invasive procedures fuels market growth

Cosmetic surgery and minimally invasive procedures such as botulinum toxin and face filler injections have grown in popularity over the last decade. Over the last few years, Americans have been spending more money on cosmetic surgery. Moreover, market participants are routinely developing technologically sophisticated products, which may boost segmental expansion throughout the forecast period. For instance, Revance (US), launched the RHA (resilient hyaluronic acid) filler line in August 2020. 

The resilient hyaluronic acid fillers are meant to adjust to face dynamics and are the initial stage in a range of treatments for aesthetic practices. Such factors, together with technical improvements in equipment and rising awareness about cosmetic surgery, are likely to drive the market of cosmetic surgery throughout the forecast period.

Increasing awareness and education regarding cosmetic surgery significantly impact the Global Cosmetic Surgery Market Industry. Educational campaigns and resources provided by medical professionals and associations help demystify procedures, addressing common misconceptions and fears. This proactive approach fosters informed decision-making among potential patients, leading to higher rates of consultation and procedure uptake. As individuals become more knowledgeable about the benefits and risks associated with cosmetic surgery, the market is likely to expand. Furthermore, the rise of online platforms offering detailed information and patient testimonials contributes to a more educated consumer base, ultimately driving market growth.

The proliferation of cosmetic surgery clinics worldwide contributes to the growth of the Global Cosmetic Surgery Market Industry. Increased accessibility to surgical procedures is facilitated by the establishment of specialized clinics that cater to diverse demographics. These facilities often offer competitive pricing and tailored services, making cosmetic surgery more attainable for a broader audience. The expansion is particularly pronounced in emerging markets, where rising disposable incomes and changing beauty standards create new opportunities for growth. As the number of clinics increases, so does the availability of advanced technologies and skilled practitioners, further enhancing the industry's appeal.

The Global Cosmetic Surgery Market Industry experiences a notable surge in demand for aesthetic procedures, driven by increasing societal acceptance of cosmetic enhancements. This trend is particularly evident among younger demographics, who are more inclined to pursue surgical options to enhance their appearance. As of 2024, the market is valued at approximately 60.2 USD Billion, reflecting a growing consumer base that prioritizes personal aesthetics. The proliferation of social media platforms further fuels this demand, as individuals seek to emulate the looks of influencers and celebrities. This cultural shift towards self-improvement and body positivity is likely to sustain growth in the industry.

The Global Cosmetic Surgery Market Industry is poised for substantial growth, with projections indicating a market value of 135.5 USD Billion by 2035. This growth trajectory, characterized by a compound annual growth rate (CAGR) of 7.65% from 2025 to 2035, suggests a robust demand for cosmetic procedures driven by evolving consumer preferences and economic factors. As disposable incomes rise globally, individuals are more willing to invest in personal aesthetics, viewing cosmetic surgery as a viable means of enhancing their quality of life. This economic empowerment, coupled with a cultural shift towards self-expression, is likely to sustain the industry's expansion.

Technological innovations play a pivotal role in shaping the Global Cosmetic Surgery Market Industry. The introduction of minimally invasive techniques, such as endoscopic surgery and laser-assisted procedures, has revolutionized the field, offering patients reduced recovery times and lower risks of complications. These advancements not only enhance the safety and efficacy of procedures but also attract a broader audience, including those who may have previously hesitated due to fears associated with traditional surgery. As the industry evolves, the integration of artificial intelligence and virtual reality in pre-operative planning and patient education is anticipated to further enhance patient experiences and outcomes.

By Region, the study segments the market into North America, Europe, Asia-Pacific, and Rest of the World. The North America cosmetic surgery market accounted for the largest market share in 2022, due to the developed healthcare infrastructure, a high number of surgeries performed in the region, and the presence of major key players in the region such as AbbVie (US), Cynosure (US), Solta Medical (US), and Candela Corporation (US), are some factors driving growth for the North America cosmetic surgery market. 

According to Aesthetic Plastic Surgery Statistics, surgical procedures climbed by 54%, while non-surgical surgeries increased by 44%. In 2021, the typical plastic surgeon conducted 320 surgical procedures, up from 220 in 2020. Additionally, in 2021, 365,000 breast augmentations were performed (+44%).  Furthermore, 148,000 women had their implants removed and replaced (+32% from 2020), whereas 71,000 had their implants removed but not replaced (+47%).

Further, the major countries will be study are: The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: COSMETIC SURGERY MARKET BY REGION 2022 & 2030

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe cosmetic surgery market accounted for the second-largest market share due to technology advancements, increasing healthcare expenditure, and increasing prevalence of skin diseases. For instance, according to the British Association of Aesthetic Plastic Surgeons (BAAPS), approximately 27,000 operations were performed in 2019, with breast augmentation being the most popular procedure. Furthermore, the Germany cosmetic surgery attributed to hold the largest market share, and the France cosmetic surgery is projected be the fastest growing market in the Europe region.

The Asia-Pacific cosmetic surgery market is expected to be the fastest growing from 2023 to 2030 owing to countries such as China, India, and South Korea which support the region. South Korea is known as a cosmetic surgery hub, which aids industry growth. The availability of technologically sophisticated items, as well as the increased emphasis on physical attractiveness, are expected to drive the regional market. Moreover, China cosmetic surgery accounted to hold the largest market share, and the India cosmetic surgery is projected to be the fastest growing market in the Asia-Pacific region.

Major market players R&D investments, rising number of skin diseases, and improved product quality, and the rise in per capita income of the consumers make the cosmetic surgery market lucrative. To expand their reach and optimize their operating costs, the major players focus on obtaining regulatory authorizations from government agencies for their products and emphasize acquisitions and product launches to gain a substantial market share.

The debut of AvéliTM, a revolutionary new cellulite device, has been announced by Revelle Aesthetics, Inc., a Silicon Valley MedTech business funded by venture capital. The company is focused on inventing precision solutions that attack the underlying cause of women's most irritating aesthetic concerns in 2022. 

The goal of Revelle is to create intelligent, aesthetically pleasing solutions that give practitioners dependable results and significant results for women. At the annual plastic surgery conference of The Aesthetic Society, the company recently unveiled Avéli, an FDA-cleared device that temporarily* diminishes the appearance of cellulite on the buttocks and thighs in a single procedure.

In 2018, a chain of dermatological and plastic surgery centers received approval from the Drug Controller General of India (DCGI) — The Esthetic Clinics, which conducts clinical studies and drug research for cosmetology, cosmetic surgery technologies, and pharmaceuticals for skin, hair, and other plastic surgery conditions in India. The program will lower the cost of product testing while facilitating the quicker release of more advanced, cutting-edge cosmetic, dermatological, and plastic surgery goods.

The benefit to Indian pharmaceutical businesses is that they will be able to conduct trials without having to travel overseas because they will have access to high-quality research facilities, clinicians, and laboratories within India.

AbbVie, Inc. (AbbVie) is a global, research-based biopharmaceutical company specializing in manufacturing and marketing well-known brands such as Humira and Imbruvica. The company manufactures, develops, and commercializes pharmaceutical products and biological products for patients worldwide. It has a comprehensive product portfolio that has leadership positions in key therapeutic areas of immunology, hematologic oncology, neuroscience, eye care, and women's health. 

It creates next-generation gene therapies for patients who need them and whose illnesses could benefit. It is committed to discovering and delivering a constant supply of innovative new medicines with distinct and compelling benefits in more than 70 countries worldwide.

Candela is a medical aesthetic device company. The company's technologies enable physicians to provide advanced energy-based solutions for a broad range of medical aesthetic applications including treatment of benign vascular and pigmented lesions, scars, facial resurfacing, wrinkle reduction, acne, leg veins, cellulite, body shaping, women's health, and tattoo and hair removal. It is the legal producer of multiple products branded under the Candela name including the Profound, CO2RE, CO2RE Intima, UltraShape, elōs plus, eTwo, VelaShape system families.

Moreover, In February 2023, Candela Introduced the new FDA-cleared Profound Matrix System. This multi-application solution, designed to repair, preserve, and restore skin at various stages of ageing, includes Sublime, Sublative RF, and all-new Matrix Pro applicators.